{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:37:44Z","timestamp":1761187064173,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Data in Brief"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.dib.2025.111802","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:49:43Z","timestamp":1750261783000},"page":"111802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dataset of pharmacotherapy in autism spectrum disorder"],"prefix":"10.1016","volume":"61","author":[{"given":"Sebasti\u00e3o Gon\u00e7alves de Barros","family":"Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Oliveira","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renandro de Carvaho","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-7323","authenticated-orcid":false,"given":"Kelson James da Silva","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Decio","family":"Brunoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3191-9146","authenticated-orcid":false,"given":"Roberta Monterazzo","family":"Cysneiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders","key":"10.1016\/j.dib.2025.111802_bib0001"},{"key":"10.1016\/j.dib.2025.111802_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","article-title":"Prevalence and Characteristics of autism spectrum disorder among children aged 8 years \u2014 autism and developmental disabilities monitoring network, 11 sites, United States, 2020","volume":"72","author":"Maenner","year":"2023","journal-title":"MMWR Surveill. Summar."},{"key":"10.1016\/j.dib.2025.111802_bib0003","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/15374416.2015.1077448","article-title":"Evidence base update for autism spectrum disorder","volume":"44","author":"Smith","year":"2015","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.dib.2025.111802_bib0004","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.ridd.2013.05.028","article-title":"Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany","volume":"34","author":"Bachmann","year":"2013","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.dib.2025.111802_bib0005","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1007\/s10803-019-04154-2","article-title":"Clinical profile of autism spectrum disorder in a pediatric population from Northern Mexico","volume":"49","author":"Gonz\u00e1lez-Cort\u00e9s","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.dib.2025.111802_bib0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psychres.2019.04.013","article-title":"Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: a cross-sectional study","volume":"276","author":"Fusar-Poli","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.dib.2025.111802_bib0007","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3346\/jkms.2017.32.10.1687","article-title":"Prescription trends of psychotropics in children and adolescents with autism based on nationwide health insurance data","volume":"32","author":"Hong","year":"2017","journal-title":"J. Korean Med. Sci."},{"doi-asserted-by":"crossref","unstructured":"D.S. Mandell, K.H. Morales, S.C. Marcus, A.C. Stahmer, J. Doshi, D.E. Polsky, Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders, Pediatrics 121 (2008) e441\u2013e448. https:\/\/doi.org\/10.1542\/peds.2007-0984.","key":"10.1016\/j.dib.2025.111802_bib0008","DOI":"10.1542\/peds.2007-0984"},{"key":"10.1016\/j.dib.2025.111802_bib0009","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/cap.2017.0092","article-title":"Characteristics associated with drug prescription and compliance among young children with autism spectrum disorder","volume":"28","author":"Meiri","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.dib.2025.111802_bib0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/1362361313497537","article-title":"Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program","volume":"18","author":"Schubart","year":"2014","journal-title":"Autism"},{"key":"10.1016\/j.dib.2025.111802_bib0011","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.2147\/NDT.S277294","article-title":"Pharmacological intervention in children with autism spectrum disorder with standard supportive therapies significantly improves core signs and symptoms: a single-center, retrospective case series","volume":"16","author":"Alsayouf","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.dib.2025.111802_bib0012","first-page":"250","article-title":"Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders","volume":"48","author":"Lamy","year":"2018","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"10.1016\/j.dib.2025.111802_bib0013","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1017\/S0033291716003457","article-title":"A comprehensive systematic review and meta-analysis of pharmacological and dietary supplement interventions in paediatric autism: moderators of treatment response and recommendations for future research","volume":"47","author":"Masi","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.dib.2025.111802_bib0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/acps.12644","article-title":"Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review","volume":"135","author":"Jobski","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.dib.2025.111802_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00304","article-title":"Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder","volume":"12","author":"Eissa","year":"2018","journal-title":"Front. Neurosci."},{"doi-asserted-by":"crossref","unstructured":"R. Vohra, S. Madhavan, U. Sambamoorthi, C. StPeter, S. Poe, N. Dwibedi, M. Ajmera, Prescription drug use and polypharmacy among medicaid-enrolled adults with autism: a retrospective cross-sectional analysis, Drugs Real World Outcomes 3 (2016) 409\u2013425. https:\/\/doi.org\/10.1007\/s40801-016-0096-z.","key":"10.1016\/j.dib.2025.111802_bib0016","DOI":"10.1007\/s40801-016-0096-z"},{"issue":"suppl 2","key":"10.1016\/j.dib.2025.111802_bib0017","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1590\/s1518-8787.2016050006156","article-title":"National survey on access, use and promotion of rational use of medicines (PNAUM): household survey component methods","volume":"50","author":"Mengue","year":"2016","journal-title":"Rev. Saude Publ."}],"container-title":["Data in Brief"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340925005293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340925005293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:11:35Z","timestamp":1761185495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352340925005293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":17,"alternative-id":["S2352340925005293"],"URL":"https:\/\/doi.org\/10.1016\/j.dib.2025.111802","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/data.mendeley.com\/datasets\/sgvb7sh4yn\/5","asserted-by":"subject"}]},"ISSN":["2352-3409"],"issn-type":[{"type":"print","value":"2352-3409"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dataset of pharmacotherapy in autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Data in Brief","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dib.2025.111802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111802"}}